Home > Boards > US Listed > Cannabis > InMed Pharmaceuticals Inc. (INM)

All I'll say is, wait until the uplist.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Bing420 Member Profile
 
Followed By 2
Posts 138
Boards Moderated 0
Alias Born 06/05/14
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 9/24/2021 4:08:11 PM
InMed Pharmaceuticals Reports Full Year Fiscal 2021 Financial Results and Provides Business Update GlobeNewswire Inc. - 9/24/2021 7:30:00 AM
InMed Pharmaceuticals to Report Full Year Fiscal 2021 Financial Results and Business Update on September 24, 2021 GlobeNewswire Inc. - 9/17/2021 1:14:44 PM
InMed Pharmaceuticals and BayMedica Participating in Tribe Public’s Webinar "Accelerating The Commercialization of Rare Cannabinoids" GlobeNewswire Inc. - 9/17/2021 7:30:00 AM
Cannabis Industry Investor Presentations Now Available for On-Demand Viewing PR Newswire (Canada) - 9/13/2021 8:43:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2021 8:01:26 AM
Cannabis Industry Investor Presentations Now Available for On-Demand Viewing PR Newswire (US) - 9/13/2021 7:32:00 AM
InMed Pharmaceuticals Signs Definitive Agreement to Acquire BayMedica, a Leading Commercial Manufacturer of Rare Cannabinoids GlobeNewswire Inc. - 9/13/2021 7:30:00 AM
InMed Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference GlobeNewswire Inc. - 9/9/2021 7:18:38 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/8/2021 6:05:39 AM
InMed Pharmaceuticals to Webcast Live at VirtualInvestorConferences.com September 8th PR Newswire (US) - 9/7/2021 4:04:00 PM
Cannabis Executives Present: Cannabis Investor Conference September 8th & 9th PR Newswire (Canada) - 9/3/2021 8:35:00 AM
Cannabis Industry Investor Conference: Company Executives Present September 8th & 9th PR Newswire (US) - 9/2/2021 8:35:00 AM
InMed Pharmaceuticals to Present at the H.C. Wainwright Ophthalmology Virtual Conference GlobeNewswire Inc. - 8/12/2021 12:00:00 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 7/23/2021 6:05:12 AM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 7/19/2021 6:14:18 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 7/13/2021 6:01:34 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/2/2021 4:28:09 PM
InMed Pharmaceuticals Announces Closing of US$12 Million Private Placement Priced At-the-Market under Nasdaq Rules GlobeNewswire Inc. - 7/2/2021 4:15:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/30/2021 6:01:59 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/29/2021 3:13:15 PM
InMed Pharma signs LOI to acquire rare cannabinoids manufacturer BayMedica Seeking Alpha - 6/29/2021 7:42:06 AM
InMed Pharma shares climb on launch of $12M private placement Seeking Alpha - 6/29/2021 7:31:27 AM
InMed Pharmaceuticals Signs Non-binding Letter of Intent to Acquire BayMedica, a Commercial Manufacturer of Rare Cannabinoids... GlobeNewswire Inc. - 6/29/2021 7:00:00 AM
InMed Pharmaceuticals Announces $12 Million Private Placement Priced At-the-Market under Nasdaq Rules GlobeNewswire Inc. - 6/29/2021 7:00:00 AM
Bing420   Friday, 03/09/18 05:41:02 PM
Re: ALL-IN888 post# 5705
Post # of 9808 
All I'll say is, wait until the uplist. A whole new bunch of eyes will then be looking at us. There are some Very large investors who have internal conditions that that do not allow them to invest in firms on lower tiered exchanges.

Uplisting is a very big deal, and it will result in a change of our sp.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences